Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

PAR-22-180: Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)

Closed Closed May 16, 2025 Opportunity PAR-22-180

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.

National Institutes of Health offered grants of up to $250,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on May 16, 2025.

From the official notice on Grants.gov, last changed May 24, 2022. Checked November 7, 2026.

About this NIH notice

Projects funded under PAR-22-180 were run by National Institute of General Medical Sciences (NIGMS, 1,597 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read PAR-22-180 in the NIH Guide.

Key dates

PostedMay 24, 2022
DeadlineMay 16, 2025
Archived by Grants.govJune 21, 2025

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

The Maximizing Investigators' Research Award (MIRA) provides support for the program of research in an investigator's laboratory that is within the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. It is anticipated that this program will: Increase the stability of funding for NIGMS-supported investigators, which could enhance their ability to take on ambitious scientific projects and approach problems more creatively; Increase flexibility for investigators to follow important new research directions within the NIGMS mission as opportunities arise, rather than being bound to specific aims proposed in advance of the studies; More widely distribute funding among the nation's highly talented and promising investigators to increase overall scientific productivity and the chances for important breakthroughs; Reduce the time spent by researchers writing and reviewing grant applications, allowing them to spend more time conducting research; Enable investigators to devote more time and energy to mentoring trainees in a more stable research environment. This FOA allows applications from eligible NIGMS-funded investigators and from New Investigators proposing research within the scientific mission of NIGMS. The FOA also allows renewal applications from all current MIRA grantees (established investigators and those previously funded as early-stage investigators). PD/PIs who are currently Early Stage Investigators (ESIs) should apply through the ESI MIRA FOA and should not apply through this FOA.

Category: Health.

Funded under PAR-22-180 so far

NIH funded 1,597 projects under PAR-22-180 in fiscal 2024 to 2026, at 243 institutions. The median yearly award was $438,218.

Most projects: University of Michigan at Ann Arbor (Michigan), 44, University of Pennsylvania (Pennsylvania), 41, Stanford University (California), 40, Univ of North Carolina Chapel Hill (North Carolina), 35, Johns Hopkins University (Maryland), 35.

Recently funded projects
ProjectInstitutionFiscal yearAward
Function and Pathway outcomes of Dynamic Protein Structures R35Miami University Oxford2026$343,087
Cellular physiology of Otopetrin Proton Channels R35University of Southern California2026$412,500
Coordinated Cytoskeletal Dynamics and Membrane Remodeling in Cellular Shape Change R35Univ of North Carolina Chapel Hill2026$443,311
Methods and technologies for chemical synthesis of glycans R35Saint Louis University2026$372,023
Novel Transition Metal Catalysis for Chemical Synthesis R35University of Texas Dallas2026$432,438
Elucidating mechanisms of spermatogonial stem cell competition R35New York University School of Medicine2026$423,750
Dissecting the DNA Damage Response with Functional Proteomics R35University of Texas HLTH Science Center2026$393,750
Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis R35Oklahoma Medical Research Foundation2026$426,250

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Biomedical Research and Research Training grants before

From fiscal 2021 to 2025, Biomedical Research and Research Training (93.859) awarded $15 billion across 11,631 grant awards, an average of $1.3 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
The Leland Stanford Junior UniversityCalifornia186$290 million
Regents of the University of MichiganMichigan226$268 million
University of California, San DiegoCalifornia198$264 million
Yale UnivConnecticut195$250 million
University of Wisconsin SystemWisconsin169$241 million

Top states: California ($2.1 billion), New York ($1.4 billion), Massachusetts ($971 million), Texas ($833 million), Pennsylvania ($680 million).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is PAR-22-180 still open?

No. It closed on May 16, 2025.

Who can apply for Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)?

Closed May 16, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $250,000 each.

Who has been funded under PAR-22-180?

NIH RePORTER lists 1,597 projects funded under PAR-22-180 in fiscal 2024 to 2026, at 243 institutions. The most were at University of Michigan at Ann Arbor, University of Pennsylvania, Stanford University.

Who has won Biomedical Research and Research Training grants before?

The largest recipients over five fiscal years were The Leland Stanford Junior University, Regents of the University of Michigan, University of California, San Diego. The program made 11,631 awards worth $15 billion in that time.

Similar open grants